Latest filing published 30 Mar 2007 for Chelsea Therapeutics International, Ltd., €469k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas L. Kempner Jr.: trading record in brief
Thomas L. Kempner Jr. discloses dealings in Chelsea Therapeutics International, Ltd. to SEC (Form 4). The record holds 2 filings, for trades running from 22 February 2007 to 22 March 2007.
The open-market record is one-sided, with 2 purchases worth €612k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 30 March 2007, reports an open-market purchase of €469k in Chelsea Therapeutics International, Ltd. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Thomas L. Kempner Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 132,416 shares@ US$4.72Common Stock, $0.0001 par value ("Common Stock")SEC:0000902664-07-001349:0Canonical exit: 20 Jun 2007 (T+90)
1 of 1 declaration